Gilead Sciences (UK) Performance
| 0QYQ Stock | 90.22 0.27 0.30% |
On a scale of 0 to 100, Gilead Sciences holds a performance score of 12. The company retains a Market Volatility (i.e., Beta) of 0.23, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Gilead Sciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Gilead Sciences is expected to be smaller as well. Please check Gilead Sciences' coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to make a quick decision on whether Gilead Sciences' current trending patterns will revert.
Risk-Adjusted Performance
12 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Gilead Sciences unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0005 | Payout Ratio 0.3682 |
1 | Gilead Sciences Stock Slides as Market Rises Facts to Know Before You Trade - Yahoo Finance | 09/24/2024 |
2 | Gilead Sciences stock hits 52-week high at 98.34 - Investing.com | 11/11/2024 |
| Dividend Yield | 0.0501 | |
| Payout Ratio | 0.3682 |
Gilead |
Gilead Sciences Relative Risk vs. Return Landscape
If you would invest 7,816 in Gilead Sciences on August 30, 2024 and sell it today you would earn a total of 1,206 from holding Gilead Sciences or generate 15.43% return on investment over 90 days. Gilead Sciences is generating 0.2343% of daily returns and assumes 1.4305% volatility on return distribution over the 90 days horizon. Simply put, 12% of stocks are less volatile than Gilead, and 96% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Gilead Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gilead Sciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Gilead Sciences, and traders can use it to determine the average amount a Gilead Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1638
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 0QYQ | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.43 actual daily | 12 88% of assets are more volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Gilead Sciences is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gilead Sciences by adding it to a well-diversified portfolio.
Gilead Sciences Fundamentals Growth
Gilead Stock prices reflect investors' perceptions of the future prospects and financial health of Gilead Sciences, and Gilead Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Gilead Stock performance.
| Return On Equity | 0.0056 | ||||
| Return On Asset | 0.12 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.42 % | ||||
| Current Valuation | 131.81 B | ||||
| Revenue | 28.3 B | ||||
| Gross Profit | 21.62 B | ||||
| EBITDA | 13.95 B | ||||
| Net Income | 5.67 B | ||||
| Book Value Per Share | 14.83 X | ||||
| Cash Flow From Operations | 9.07 B | ||||
| Total Asset | 67.95 B | ||||
| Retained Earnings | 15.69 B | ||||
About Gilead Sciences Performance
Assessing Gilead Sciences' fundamental ratios provides investors with valuable insights into Gilead Sciences' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Gilead Sciences is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Gilead Sciences is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about Gilead Sciences performance evaluation
Checking the ongoing alerts about Gilead Sciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Gilead Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 88.0% of the company shares are owned by institutions such as pension funds | |
| Latest headline from news.google.com: Gilead Sciences stock hits 52-week high at 98.34 - Investing.com |
- Analyzing Gilead Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Gilead Sciences' stock is overvalued or undervalued compared to its peers.
- Examining Gilead Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Gilead Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Gilead Sciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Gilead Sciences' stock. These opinions can provide insight into Gilead Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Gilead Stock Analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.